479Wire StoriesIronNet Wins Award for Advanced Persistent Threat Detection
Cyber Defense Magazine Recognizes IronNet with 2022 Global InfoSec Award MCLEAN, Va.–(BUSINESS WIRE)–$IRNT–IronNet, Inc. (NYSE: IRNT), an innovative leader Transforming Cybersecurity Through...
- 566Wire Stories
SCIEX Launches the Next Generation of Data Independent Acquisition With Zeno SWATH DIA at ASMS 2022
Enabling biomarker discovery and translation through increased sensitivity, throughput and robustness. FRAMINGHAM, Mass.–(BUSINESS WIRE)–#ASMS—SCIEX, a global leader in life science analytical technologies,...
- 541Wire Stories
SCIEX Launches the New Cornerstone of Software Ecosystem – SCIEX OS 3.0
Features include Zeno SWATH DIA, stMRM, an integrated central console and accessibility across 9 languages FRAMINGHAM, Mass.–(BUSINESS WIRE)–#ASMS–At ASMS 2022, SCIEX, a...
- 507Wire Stories
TXOne Networks Expands U.S. Footprint to Address American Industry’s Growing Need for OT Zero Trust Cybersecurity to Prevent Disruption from Modern Digital Threats
IRVING, Texas & TAIPEI, Taiwan–(BUSINESS WIRE)–#ARCForum—TXOne Networks, the global leader of operational technology (OT) zero trust cybersecurity, announced today the expansion of...
- 648News
Insilico Medicine Raises $60 Million in Series D Financing to Advance Pipeline and Launch AI-powered Drug Discovery Robotics Laboratory
BEIJING, CHINA – Media OutReach – 6 June 2022 – Insilico Medicine, a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, announced...
- 751Wire Stories
Emera Technologies and NOVONIX Launch Made-In-Atlantic-Canada Microgrid Battery
HALIFAX, Nova Scotia & BRISBANE, Australia–(BUSINESS WIRE)–Today Emera Technologies Limited, a subsidiary of Emera Inc. (TSX:EMA), and NOVONIX Limited (NASDAQ: NVX, ASX:...
- 759Wire Stories
AnHeart Therapeutics and Innovent Biologics Present Updated Phase 2 Efficacy and Safety Data of Taletrectinib (ROS1 Inhibitor) at ASCO 2022
In 67 ROS1 TKI-naïve patients, the confirmed objective response rate (cORR) and disease control rate (DCR) were 92.5% and 95.5%, respectively. In...
- 694Wire Stories
Genuv Teams With Nanocarry Therapeutics to Develop Novel anti-PD-1 mAb Treatments That Can Cross the Blood-Brain Barrier
Collaboration to explore the use of Nanocarry’s bioengineered nanoparticles to deliver treatments to intractable brain tumors SEOUL, South Korea & NESS ZIONA,...
- 548Wire Stories
Data443 Appoints IP Leader and Chief Legal Officer Ms. Pamela Maher
Recognized Expert on IP Law – Fresh off Recent Large IPO for Medical Software Device and Services provider in Silicon Valley RESEARCH...
- 553Wire Stories
ScoutCam Completes Verification & Validation for Miniature Camera Solution with Fortune 500 Customer
Milestone Highlights Ongoing Market Adoption of Company Technology Omer, Israel, June 06, 2022 (GLOBE NEWSWIRE) — ScoutCam Inc. (OTCQB: SCTC) (“ScoutCam” or...
